Regulatory clearance for Alere flu test

|About: Alere Inc. (ALR)|By:, SA News Editor

Via its 510k process, the FDA approves Alere's (ALR +1.9%) i Influenza A&B diagnostic test, the only molecular test that can detect and differentiate the influenza A and B virus in less than 15 minutes. The product was launched in Europe earlier this year.

The firm has rapid molecular tests in development for Strep A, C. difficile, RSV and chlamyida/gonorrhea.